Structure of the active manganese catalyst in water.
Photo: University of Göttingen
Chemists at the University of Göttingen develop resource-saving process
For the production of drugs, pesticides and smartphone displays, most of the processes are cost-intensive and generate a large amount of waste. Scientists at the University of Göttingen have now succeeded in developing a resource-saving “green” alternative. The results were published in Nature Catalysis.
The environmentally friendly strategy developed by Professor Lutz Ackermann and his team at the Institute of Organic and Biomolecular Chemistry at the University of Göttingen offers major advantages over existing methods. The naturally occurring non-toxic metal manganese is employed instead of noble transition metals such as palladium or platinum. Traditionally, organic solvents, which are highly flammable and toxic, were also used. In contrast, the new approach makes use of environmentally-friendly water. This is possible because a manganese-carbon bond is formed in the reaction. This bond is considerably more stable than comparable bonds between carbon and the highly reactive metals lithium or magnesium.
“The new process makes it possible to cleave a single strong carbon-carbon bond, of which organic compounds contain a large number, and convert it into the desired product,” says Ackermann. In order to achieve the results, experimental laboratory investigations were combined with computer-aided calculations. “This allowed us to gain detailed insight into the exact mode of action of the catalyst. And this in turn enables us to use the process to manufacture other materials.”
Learn more: The new green alternative for drug production
The Latest on: Drug production
via Google News
The Latest on: Drug production
- Federal ruling against a Philadelphia supervised drug-use site raises questions for Seattle planson January 12, 2021 at 6:30 pm
A 2-1 ruling from the Third Circuit Court of Appeals that rejected a proposed supervised injection facility in Philadelphia will not stop Seattle's plan to provide medical supervision for drug use ...
- Travere Therapeutics Announces Orphan Drug Designation for Sparsentan for the Treatment of IgA ...on January 12, 2021 at 1:41 pm
(GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to sparsentan for the treatment of ...
- Safe Drug-Injection Site in Philly Nixed by 3rd Circuiton January 12, 2021 at 1:31 pm
After a federal judge had said it would not violate federal law for drug users to shoot up in a facility with medical supervision, the appeals court found otherwise Tuesday. A protester ...
- Large Molecule Manufacturing May Be Turning to Local Marketson January 12, 2021 at 12:00 pm
Pharmaceutical companies may be turning to manufacturers close to their markets, according to a U.S.-based CDMO ...
- Pfizer ramps up vaccine production to 2 billion doses for 2021on January 12, 2021 at 11:15 am
Albert Bourla, Pfizer's chairman and CEO, told stakeholders the pharmaceutical giant will increase its original goal for producing the coronavirus vaccine.
- Swiss drugs regulator approves Moderna’s COVID-19 vaccineon January 12, 2021 at 9:56 am
Switzerland approved Moderna Inc's COVID-19 vaccine on Tuesday, making it the second shot after Pfizer and BioNTech's to be approved in the country and clearing the way to get up to 1.5 million doses ...
- 5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rightson January 12, 2021 at 3:12 am
CNW/ - 5N Plus Inc. ("5N Plus"), a leading global producer of specialty chemicals and engineered materials, and Microbion Corporation ("Microbion"), a clinical-stage pharmaceutical company focused on ...
- Anti-Suicide Drugs Market Size 2020 by Capacity, Production, Revenue, Price, Cost, Gross Margin Analysis and Forecast to 2024on January 11, 2021 at 10:14 pm
Final Report will add the analysis of the impact of COVID-19 on this industry." Depression is one of the major ...
- Chicopee, Springfield residents arrested after drug cultivation, manufacturing operation uncoveredon January 8, 2021 at 10:00 am
Two people accused of manufacturing THC extract oil and a psychedelic drug and growing marijuana without a license were arrested after firefighters uncovered the illegal drug operation while ...
- Injectable Drug Delivery Devices Market Size 2021 Production, Market Share, Price, Growth Rate and Future Expectations to 2025on January 6, 2021 at 4:06 am
Final Report will add the analysis of the impact of COVID-19 on this industry." The Injectable Drug Delivery Devices market revenue was 11305 Million USD in 2019, and will reach 20302 Million USD in ...
via Bing News
